Multiple myeloma (MM) is characterized by a proliferation of malignant plasma cells with strong dependence on the bone marrow (BM) microenvironment. In fact, MM is considered the prototype of cancer in which the malignant cells interact with the microenvironment.[1][1],[2][2] It has recently been
No takes yet. Share an insight, caveat, or question.
Bladé et al. (2012) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: